The High Flux Reactor in Petten, the Netherlands, is back online after its lengthy unscheduled closure, following special approval from the Dutch Council of Ministers.
The High Flux Reactor in Petten, the Netherlands, is back online after its lengthy unscheduled closure, following special approval from the Dutch Council of Ministers.
The decision should allow supplies of molybdenum-99 to stabilize after six months of periodic shortages and avert an immediate supply crunch. Both other sites in Europe that produce Mo-99 are currently closed for routine maintenance.
"With the restart of the HFR, it is expected that within a few days there will be sufficient availability of medical isotopes for the treatment of patients worldwide," said a statement from the Nuclear Research and Consultancy Group (NRG), the company that runs the Petten reactor.
The Dutch reactor was initially shut down in August 2008 after a small bubble jet was observed in its primary water cooling system. The coolant pipes are also known to have been deformed, with the pipe walls thinning from 9.5 mm to 3 or 4 mm in places.
Planned repairs to the primary cooling system have not yet been carried out. Dutch officials have nonetheless agreed that the reactor can begin operating again so long as additional safety measures are adhered to.
The NRG has fitted seals to contain water escaping from the pipes and installed additional systems to monitor for leaks. Deformations to the pipe work, first noticed in 2005, will be subject to an "intensified inspection regime."
An independent team of experts from the International Atomic Energy Agency will visit the site shortly to monitor the situation. If any irregularities are detected by IAEA officials or NRG staff, the reactor will be shut down immediately.
The NRG anticipates that it will take another 12 months before it can replace the damaged sections of the primary water cooling system. The repair itself will close the reactor again for two or three months.
For more information from the Diagnostic Imaging and SearchMedica archives:
Collaboration begins on U.S. Mo-99 production facilityHigh-volume production of Mo-99 appears feasible with low-grade uraniumEuropean Mo-99 production at Petten may resume in FebruaryEurope faces further Mo-99 supply woes
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.